Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
A phase 3 trial of Leucovorin and Tegafur, gimeracil and oteracil in Colorectal cancer, run by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, completed.
Overview
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery is a phase 3 interventional study registered as NCT00660894 by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, with 1535 participants recorded, started 2008-04 and reaching its primary completion in 2012-06. Interventions recorded: folinate calcium, tegafur-uracil, tegafur-gimeracil-oteracil potassium. Conditions recorded: Colorectal Cancer.
Linked to the drug Tegafur, gimeracil and oteracil because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialSOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
Shares Tegafur, gimeracil and oteracil (S-1), Colorectal cancer and the tag pipeline.
- TrialPalliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialCombination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialFUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialCediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Colorectal cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Leucovorin (folinic acid) and the tag pipeline.